icd10free.comPowered by Curo

ICD-10 Coding for Wegovy® (semaglutide) for Obesity Management(E66.01, E66.0, E66.1)

Save

Comprehensive guide on ICD-10 coding for Wegovy, including documentation requirements and billing considerations for obesity management.

Also known as:
SemaglutideWegovy
Related ICD-10 Code Ranges

Complete code families applicable to Wegovy® (semaglutide) for Obesity Management

E00-E89Primary Range

Endocrine, nutritional and metabolic diseases

→
Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescription
E66.01Morbid (severe) obesity due to excess calories
E66.3Overweight
Primary ICD-10-CM Codes
Morbid (severe) obesity due to excess calories
E66.01Billable
Differential Codes

Alternative codes to consider when ruling out similar conditions

OverweightE66.3
Morbid obesityE66.01

Documentation & Coding Risks

Avoid these common issues when documenting Wegovy® (semaglutide) for Obesity Management.

Missing BMI documentation

Impact

Clinical: Inaccurate patient assessment., Regulatory: Non-compliance with coding standards., Financial: Potential claim denials.

Mitigation

Ensure BMI is recorded at each visit., Cross-check documentation before submission.

Using BMI code without primary obesity code

Impact

Reimbursement: Claims may be denied., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate representation of patient condition.

Mitigation

Always pair BMI codes with appropriate E66 codes.

BMI documentation

Impact

Inadequate BMI documentation can lead to audit findings.

Mitigation

Ensure BMI is documented at every visit.

Frequently Asked Questions

Related condition guides

Documentation requirements, coding pitfalls and FAQs for conditions coded with E66.01.